Paper9876591
Extension of the International Conference on Harmonization Tripartite Guideline for Stability Testing of New Drug Substances and Products to countries of climatic zones III and IV.
Grimm W. Drug Dev Ind Pharm, 1998. Cited by 53 papers, by iCite.
Cite this record
ConductScience Library. Extension of the International Conference on Harmonization Tripartite Guideline for Stability Testing of New Drug Substances and Products to countries of climatic zones III and IV. Papers, record 9876591. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9876591
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Extension of the International Conference on Harmonization Tripartite Guideline for Stability Testing of New Drug Substances and Products to countries of climatic zones III and IV.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Stability | Major topic |
| Climate | |
| Drug Industry | |
| Drug Labeling | |
| Drug Packaging | |
| Drug Storage | |
| Humans | |
| Safety | |
| Temperature |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40711662 | Evaluation of XSB-001 (Ranibizumab Biosimilar) Physicochemical and Biological Stability in Prepared Syringes for Intravitreal Injection. | Adv Ther | 2025 | https://conductscience.org/library/papers/40711662 | PubMed |
| 40483335 | Enhanced solubility and bioavailability of coenzyme Q10 via co-amorphous system using stevioside. | NPJ Sci Food | 2025 | https://conductscience.org/library/papers/40483335 | PubMed |
| 39771484 | Strategies to Stabilize Dalbavancin in Aqueous Solutions; Section-2: The Effects of 2 Hydroxypropyl-β-Cyclodextrin and Acetate Buffer with and Without Divalent Metal Ions. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39771484 | PubMed |
| 37697173 | Strategies to Stabilize Dalbavancin in Aqueous Solutions; Section-1: the Effects of Metal Ions and Buffers. | Pharm Res | 2023 | https://conductscience.org/library/papers/37697173 | PubMed |
| 37118348 | Strategies To Stabilize Dalbavancin in Aqueous Solutions; Section 3: The Effects of 2 Hydroxypropyl-β-Cyclodextrin and Phosphate Buffer with and without Divalent Metal Ions. | Pharm Res | 2023 | https://conductscience.org/library/papers/37118348 | PubMed |
| 36365143 | Drug Stability: ICH versus Accelerated Predictive Stability Studies. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/36365143 | PubMed |
| 35631565 | Benchmarking the Solubility Enhancement and Storage Stability of Amorphous Drug-Polyelectrolyte Nanoplex against Co-Amorphous Formulation of the Same Drug. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35631565 | PubMed |
| 35624453 | Stability of enveloped and nonenveloped viruses in hydrolyzed gelatin liquid formulation. | Virol J | 2022 | https://conductscience.org/library/papers/35624453 | PubMed |
| 35049577 | Preparation and Evaluation of Polymer-Based Ultrasound Gel and Its Application in Ultrasonography. | Gels | 2022 | https://conductscience.org/library/papers/35049577 | PubMed |
| 32454700 | Degradation Kinetics, In Vitro Dissolution Studies, and Quantification of Praziquantel, Anchored in Emission Intensity by Spectrofluorimetry. | Turk J Pharm Sci | 2019 | https://conductscience.org/library/papers/32454700 | PubMed |
| 31156916 | Shelf life after opening of prescription medicines and supplements with vitamin D3 for paediatric use. | Eur J Hosp Pharm | 2017 | https://conductscience.org/library/papers/31156916 | PubMed |
| 30510401 | A new strategy for taste masking of azithromycin antibiotic: development, characterization, and evaluation of azithromycin titanium nanohybrid for masking of bitter taste using physisorption and panel testing studies. | Drug Des Devel Ther | 2018 | https://conductscience.org/library/papers/30510401 | PubMed |
| 29187027 | Actual versus recommended storage temperatures of oral anticancer medicines at patients' homes. | J Oncol Pharm Pract | 2019 | https://conductscience.org/library/papers/29187027 | PubMed |
| 26730145 | Accelerated stability studies of Sufoofe Sailan: A Unani formulation. | Ayu | 2015 | https://conductscience.org/library/papers/26730145 | PubMed |
| 23373006 | Formulation and characterization of ketoprofen liquisolid compacts by Box-Behnken design. | Int J Pharm Investig | 2012 | https://conductscience.org/library/papers/23373006 | PubMed |
| 21605361 | The initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnership. | Malar J | 2011 | https://conductscience.org/library/papers/21605361 | PubMed |
| 21448747 | A new strategy to stabilize oxytocin in aqueous solutions: I. The effects of divalent metal ions and citrate buffer. | AAPS J | 2011 | https://conductscience.org/library/papers/21448747 | PubMed |
| 20535630 | Eudragit S-100 entrapped chitosan microspheres of valdecoxib for colon cancer. | J Mater Sci Mater Med | 2010 | https://conductscience.org/library/papers/20535630 | PubMed |
| 11571564 | Development of formulations that enhance physical stability of viral vectors for gene therapy. | Gene Ther | 2001 | https://conductscience.org/library/papers/11571564 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9876591
GET https://conductscience.org/api/papers/v1/9876591/authors